The Lynx® CDR
Connectors
Multiple, sterile connections, disconnections
and reconnections of single-use assemblies
The Lynx® CDR (Connect, Disconnect and Reconnect) device
provides a reliable and validated connection for multiple
transfers of sterile fluids. Part of the Mobius® single-use
bioprocessing family, it is designed to provide flexibility in
single use bioprocessing by enabling up to six connections,
disconnections and reconnections of multiple flow paths,
while remaining sterile and leak free.
Benefits CONNECT, DISCONNECT AND
RECONNECT IN 3 SIMPLE STEPS
• Provides multiple uses before disposal, for the
connector and associated single-use assembly Snap Slide Twist
• Eliminates the risk associated with aseptic
connections
• Validated for multiple sterile connections
/disconnections
• Bi-directional flow
• Flexibility to connect different sized tubing
The life science business of Merck operates as
MilliporeSigma in the U.S. and Canada.
Merck Millipore, the vibrant M and Lynx are
registered trademarks of Merck KGaA, Darmstadt, Germany.
© 2016 Merck KGaA, Darmstadt, Germany. All rights reserved.
RNI No. DELENG/2004/13061 Published on 28th of previous month PCW/193/2017-2019
Posting Date: 30th of every month Posted at Ex Servicemen Colony PO, Pune-38
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Indian BioSuppliers market growing at 6% touches Rs 7950 crore
The biosciences revenue of the Indian BioSuppliers market touched Rs 7950 crore in 2018-19 registering a growth of 6 per cent over previous year’s figure of Rs 7500 crore. Although India is suffering the after-effects of new tax reform applications, a massive generic drug industry and sprouting biotech startups, especially in medical and drug discovery, contract research areas, will continue to sustain growth of the market.
There are over 100 leading companies in analytical instruments space in the country who are dominating the space supported by hundreds of distributors/ channel partners spread across the country. Besides there are hundreds of small and medium size companies who have been in the business in India catering to the different requirements in public and private sectors comprising of academia, pharma and biotech companies, contract/ clinical research organisations (CROs) etc.
India still depending on the import of all kinds of analytical instruments as it is still unable to develop and manufacture these kind of high end precision equipment unlike in case of vaccines, biosimilars and blood products. However Indian companies are very much active in supplying lab consumables, kits, reagents, lab equipment, cell culture media and lab chemicals.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search